Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S15a pseudogene 40 (RPS15AP40) is a processed pseudogene in the human genome derived from the ribosomal protein S15A gene. Pseudogenes are DNA sequences similar to known genes but are generally nonfunctional due to mutations, truncations, or lack of regulatory elements. RPS15AP40 does not encode a functional ribosomal protein and is one among thousands of ribosomal protein pseudogenes distributed throughout the human genome[3]. These pseudogenes can sometimes be transcribed but do not result in a functional product. There is no evidence that RPS15AP40 serves as a therapeutic target, biomarker, or functional molecule in physiology or disease, and it is not referenced in drug interaction databases or target listings. According to the latest annotations and literature, RPS15AP40 should not be listed as a canonical target for drug discovery, disease association, or functional protein studies. Its designation as a pseudogene is supported by genomic database curation and scientific methodologies used to classify ribosomal protein pseudogenes[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S15a pseudogene 40 (RPS15AP40).